Long-term exposure to particulate matter in patients with pulmonary arterial hypertension increases risk for lung transplantation or death.

FDA’s approval of YUTREPIA paves the way for prescribers to add a new treatment option for patients with PAH and PH-ILDYUTREPIA is designed to enhance deep-lung delivery with an easy-to-use ...

U.S. FDA Approves Liquidia’s YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung ...

THOMASVILLE- Archbold is proud to welcome pulmonologist and intensivist Luis Wulff, MD, as the new Chief of Pulmonary and Critical Care Medicine at Archbold Pulmonology.

WINREVAIR is FDA-approved for the treatment of adults with pulmonary arterial hypertension (PAH, WHO Group 1) to increase exercise capacity, improve WHO functional class (FC) and reduce the risk of ...

A new study has found that asporin, a protein encoded by the ASPN gene, plays a protective role in pulmonary arterial hypertension (PAH).

A death certificate filed last week revealed the natural causes behind the death last July of Ms. O’Connor, the Irish singer and activist.

Type 2 diabetes and prediabetes can both significantly impact pulmonary health, highlighting the need for early detection and intervention.

Learn about pulmonary angiography, a method to view blood vessels near your lungs, and the differences between this method and CTA.

An angiogram is used to diagnose issues that can be treated using medication, lifestyle changes, angioplasty, or surgery.

An angiogram is a diagnostic procedure to detect heart conditions. An angioplasty is a medical treatment for certain conditions. Learn more here.